Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.00065 | 1 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.00031 | 1 |